---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-225174"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2026-05-15T10:30:06+00:00"
generated_at: "2026-05-15T10:35:12.056713+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics doubles authorized common stock to 400M shares; adds written consent right

## Summary
- Authorized common stock increased from 200M to 400M shares via charter amendment filed May 11, 2026.
- Stockholders approved the stock increase and written consent right at May 8, 2026 annual meeting.
- Written consent charter amendment and amended bylaws filed May 12, enabling stockholder action by written consent.

## SEC filing metadata
- accession: 0001193125-26-225174
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2026-05-15T10:30:06+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/0001193125-26-225174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/d157366d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-225174
- JSON: https://secwatch.observer/filing/0001193125-26-225174.json
- Plain text: https://secwatch.observer/filing/0001193125-26-225174.txt

## Key facts
- Governance Changes
  Galera Therapeutics, Inc.: Adopted Amended and Restated Bylaws providing written consent right consistent with charter amendment (effective 2026-05-12).
  - Change: bylaw amendment
  - Effective: 2026-05-12
  source text: Also on May 12, 2026, the Board of Directors of the Company approved and adopted Amended and Restated Bylaws of the Company, effective immediately. The Amended and Restated Bylaws provide stockholders with a written consent right and sets forth certain procedures associated therewith, consistent with the Written Consent Charter Amendment.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/0001193125-26-225174-index.htm
- Governance Changes
  Galera Therapeutics, Inc.: Provided stockholders with a right to act by written consent (effective 2026-05-12).
  - Change: charter amendment
  - Effective: 2026-05-12
  source text: On May 12, 2026, the Company filed a Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to provide stockholders with a right to act by written consent (the “Written Consent Charter Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/0001193125-26-225174-index.htm
- Governance Changes
  Galera Therapeutics, Inc.: Increased authorized common stock from 200 million to 400 million shares (effective 2026-05-11).
  - Change: charter amendment
  - Effective: 2026-05-11
  source text: On May 11, 2026, Galera Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 200 million shares to 400 million shares (the “Stock Increase Charter Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/0001193125-26-225174-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.